Strategic Planning
Jamr's strategic roadmap outlines four stages dedicated to addressing cardiovascular health. Let's explore each stage:
-
Stage 1 (2020-2023): Detection
During this period, Jamr focuses on researching and developing products for cardiovascular parameters detection. This includes blood pressure monitors, SpO2 monitors, ECG devices, AFib detection tools, and arteriosclerosis assessment technologies.
-
Stage 2 (2021-2025): Intervention
The second stage involves R&D, design, and production of home physical intervention devices. One such device is the ischemic preconditioning (IPC) trainer, which aims to provide interventions for individuals with cardiovascular conditions in the comfort of their homes.
-
Stage 3 (2023-2028): Treatment
In this stage, Jamr enters the medical product market and conducts research to develop professional and innovative medical products. These products will cater to the needs of clinics, hospitals, and other medical institutions, supporting effective treatment for cardiovascular health issues.
-
Stage 4 (2025-2030): Rehabilitation
During the final stage, Jamr establishes strategic cooperation with rehabilitation equipment production enterprises. This collaboration aims to aid in the recovery and rehabilitation of individuals who have experienced cardiovascular health problems, further improving their quality of life.
By progressing through these stages, Jamr aims to alleviate human suffering caused by cardiovascular health issues and enhance overall well-being.
Email Us: 
A101-301, D101-201, Jamr Science & Technology Park, No. 2 Guiyuan Road, Guixiang Community, Guanlan Street, Longhua District, Shenzhen, China